KYK-2.0 IgG1 (NCI)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameKYK-2.0 IgG1 (NCI)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionNKG2D ligands modulators
TargetsNKG2D ligands
Therapy Area/IndicationsAutoimmune DiseasesNeoplasmsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesNeoplasmsCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A